About Semba Biosciences
Semba Biosciences is a company based in Madison (United States) founded in 2005 was acquired by Tosoh Bioscience in October 2021.. Semba Biosciences has raised $5.85 million across 10 funding rounds from investors including Wisconsin Department of Commerce, Tosoh Bioscience and WEDC. Semba Biosciences operates in a competitive market with competitors including ChromaTan, Reach Separations, Sepax Technologies, Knauer and BIA Separations, among others.
- Headquarter Madison, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Semba Biosciences Inc
-
Annual Revenue
$00as on Dec 22, 2010
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.85 M (USD)
in 10 rounds
-
Latest Funding Round
$3 M (USD), Series A
Nov 29, 2018
-
Investors
Wisconsin Department of Commerce
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Tosoh Bioscience
(Oct 04, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Semba Biosciences
Semba Biosciences has successfully raised a total of $5.85M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series A — $3.0M
-
First Round
First Round
(01 Nov 2007)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Series A - Semba Biosciences | Valuation | Tosoh Bioscience |
|
| Jan, 2015 | Amount | Grant - Semba Biosciences | Valuation |
investors |
|
| Jan, 2015 | Amount | Seed - Semba Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Semba Biosciences
Semba Biosciences has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Wisconsin Department of Commerce, Tosoh Bioscience and WEDC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed venture capital funding is provided by Kegonsa Seed Fund.
|
Founded Year | Domain | Location | |
|
Offers biomolecular separation instruments and clinical analyzers for healthcare applications.
|
Founded Year | Domain | Location | |
|
Economic development support is provided for businesses and communities in Wisconsin.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Semba Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Semba Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Semba Biosciences Comparisons
Competitors of Semba Biosciences
Semba Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Reach Separations, Sepax Technologies, Knauer and BIA Separations, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| domain | founded_year | HQ Location |
Small molecule analysis and purification services are provided using chromatography.
|
|
| domain | founded_year | HQ Location |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provides liquid chromatography solutions
|
|
| domain | founded_year | HQ Location |
Monolithic chromatographic columns are developed using Convective Interaction Media technology.
|
|
| domain | founded_year | HQ Location |
Biomolecular separation technologies are enabled for bioprocessing applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Semba Biosciences
Frequently Asked Questions about Semba Biosciences
When was Semba Biosciences founded?
Semba Biosciences was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Where is Semba Biosciences located?
Semba Biosciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Is Semba Biosciences a funded company?
Semba Biosciences is a funded company, having raised a total of $5.85M across 10 funding rounds to date. The company's 1st funding round was a Seed of $511.18K, raised on Nov 01, 2007.
What does Semba Biosciences do?
Semba Biosciences was founded in 2005 in Madison, United States, and operates in the biotechnology sector. Continuous chromatography platforms for process development and single-use manufacturing are offered, along with columns for small molecule and biomolecular separation, and related reagents. These products are applied in the separation of monoclonal antibodies, recombinant proteins, natural products such as nutraceuticals and food ingredients, sugars, amino acids, organic acids, fatty acids, and enantiomers.
Who are the top competitors of Semba Biosciences?
Semba Biosciences's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Who are Semba Biosciences's investors?
Semba Biosciences has 6 investors. Key investors include Wisconsin Department of Commerce, Tosoh Bioscience, WEDC, Wisconsin SBIR, and Madison Development.